Roboleo & Co (@Roboleo_Co) header
Roboleo & Co (@Roboleo_Co) profile picture

Pharmaceutical and Healthcare Market Access Consultancy

York
Joined February 2010
Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)Photo by Roboleo & Co (@Roboleo_Co)
Roboleo & Co retweeted
The Innovative Devices Access Pathway pilot launched today. It has the potential to expedite patient access to innovative technologies by providing innovators and manufacturers with multi-partner support and targeted scientific advice. Learn more: gov.uk/government/news/uk-pa… #IDAP
2
4
1
4
10,508
Roboleo & Co retweeted
Join our webinar on the future of the UK's #AntimicrobialResistance model. Learn about the subscription model recently piloted in England (and proposals for its expansion), where companies pay a fixed annual fee based on value to the NHS, not volume sold: web.cvent.com/event/da58da2a…
1
1
2,982
Here is the link for the updated NICE Methods and Processes for Health Technology Evaluation with respect to a for Managed Access nice.org.uk/process/pmg36/ch…
NICE charges for Technology Appraisals and Highly Specialised Technologies have been updated and effective from 1 April 2022. The discount for SMEs remains at 75%. nice.org.uk/about/what-we-do…
NICE has confirmed changes to the way it evaluates medicines and other health technologies. This is to ensure patients have earlier access to innovative treatments by offering greater flexibility re: value for money and the evidence base necessary nice.org.uk/about/what-we-do…
1
NICE has today published details of the outcome of the NICE methods and processes review in a paper ahead of tomorrow’s board meeting nice.org.uk/Media/Default/Ge…
First-ever UN Resolution on persons with rare diseases paves the way for Europe’s Action Plan for Rare Diseases eurordis.org/news/un-resolut…
NHS sets aside £340m for new Innovative Medicines Fund pharmaphorum.com/
Gov’t sets out ten-year strategy for the UK’s life sciences sector pharmatimes.com/news/govt_se…
The MHRA has today published its new Delivery Plan 2021-23 - with the focus on delivering meaningful outcomes for patients and protecting public health through excellence in regulation and science. assets.publishing.service.go…
Delighted to announce ROBOLEO & CO now appointed as a NICE META tool facilitating organisation. This process helps developers of med-tech innovations to identify key evidence gaps and optimise their development plans see meta.nice.org.uk and roboleo.com
1
A new Medical Technologies (‘Med Tech’) Directorate in the Department, has been announced by Steve Oldfield, Chief Commercial Officer
NICE 5-year strategy sets out how they'll work across the health and care system and life sciences sector nice.org.uk/about/who-we-are…
The MHRA has published a case study on the Early Access to Medicines Scheme (EAMS). Includes details of a post-EAMS pilot (PEAMS) to bridge the gap between EAMS and routine access, see: gov.uk/government/case-studi…
2